In addition, the proportion of T cells at the tumor site was analyzed and the results revealed that more T cells were detected at the tumor site of IL15C-NKG2D-CAR T group, and more CD8+ T cells as well (Figures 5G, H). This evidence concerns the gene CD8A and neoplasm.